-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M9dfu53CBYP9nAEhsDrCyBklcKTWFd0bgaOejgrNOZGeALQLv3KidzD1irq/8BxC BunZAiW0WV2W3zLpOD/JUA== 0000950168-97-001856.txt : 19970714 0000950168-97-001856.hdr.sgml : 19970714 ACCESSION NUMBER: 0000950168-97-001856 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970630 FILED AS OF DATE: 19970711 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 97639541 BUSINESS ADDRESS: STREET 1: 7620 S W BRIDGEPORT RD CITY: PORTLAND STATE: OR ZIP: 97224 BUSINESS PHONE: 5036397221 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 COMPANY DATA: COMPANY CONFORMED NAME: ARIES TRUST CENTRAL INDEX KEY: 0001017537 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128325700 4 1 THE ARIES FUND FORM 4 FORM 4 OMB APPROVAL ___ Check this box if no longer subject OMB Number: 3235-0287 to Section 16. Form 4 or Form 5 Expires: April 30, 1997 obligations may continue. Estimated average burden hours per response...0.5 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1949 _______________________________________________________________________________ 1. Name and Address of Reporting Person The Aries Fund, A Cayman Island Trust* c/o Paramount Capital Asset Management, Inc - ----------------------------------------------------- (Last) (First) (Middle) 787 Seventh Avenue - ----------------------------------------------------- (Street) New York, NY 10019 - ----------------------------------------------------- (City) (State) (Zip) _______________________________________________________________________________ 2. Issuer Name and Ticker or Trading Symbol Bioject Medical Technologies, Inc. (BJCT) _______________________________________________________________________________ 3. IRS or Social Security Number of Reporting Person (Voluntary) _______________________________________________________________________________ 4. Statement for Month/Year June 1997 _______________________________________________________________________________ 5. If Amendment, Date of Original (Month/Year) _______________________________________________________________________________ 6. Relationship of Reporting Person to Issuer (Check all applicable) ___ Director ___ Officer (give title below) _X_ 10% Owner ___ Other (specify below) -------------------------------------------------- _______________________________________________________________________________
TABLE I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------ 1. 2. 3. 4. 5. 6. 7. - --------------------- -------- ---------- ------------------------------ ----------- ---------- ---------- Amount of Owner- Securities ship Trans- Trans- Securities Acquired (A) Beneficially Form: action action or Disposed of (D) Owned at Direct Nature of Date Code (Instr. 3, 4 and 5) End of (D) or Indirect Title of (Month/ (Instr. 8) ---------------------------- Month Indirect Beneficial Security Day/ ---------- Amount (A) or Price (Instr. (I) Ownership (Instr. 3) Year) Code V (D) 3 and 4) (Instr. 4) (Instr. 4) - --------------------- -------- ---- ---- ----------- ------ --------- ----------- ---------- ---------- Common Stock 6/2/97 S 13,500 D $.828 771,000 D Common Stock 6/3/97 S 14,000 D $.765 771,000 D Common Stock 6/4/97 S 23,900 D $.711 771,000 D Common Stock 6/10/97 S 10,000 D $.625 771,000 D Common Stock 6/11/97 S 1,600 D $.625 771,000 D Common Stock 6/11/97 S 6,500 D $.625 771,000 D Common Stock 6/12/97 S 10,000 D $.625 771,000 D Common Stock 6/17/97 S 33,000 D $.625 771,000 D Common Stock 6/19/97 S 6,500 D $.625 771,000 D Page 1 of 3 Common Stock 6/20/97 S 27,000 D $.625 771,000 D Common Stock 6/20/97 S 35,000 D $.625 771,000 D Common Stock 6/23/97 S 16,500 D $.625 771,000 D Common Stock 6/24/97 S 33,000 D $.625 771,000 D Common Stock 6/26/97 S 33,000 D $.631 771,000 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Page 2 of 3
TABLE II--Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g. puts, calls, warrants, options, convertible securities) - ------------------------------------------------------------------------------------------------------------------------------ 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. - ---------- -------- -------- -------- ---------- ------------ -------------- ------ ---------- --------- ---------- Title and Ownership Number of Date Exer- Amount of Form of Derivative cisable and Underlying Number of Deriv- Securities Expiration Securities Price Derivative ative Conver- Trans- Acquired (A) Date (Month/ (Instr. 3 of Securities Security: sion or Trans- action or Disposed Day/Year) and 4) Deriv- Benefi- Direct Exercise action Code of (D) -------------- -------------- ative cially (D) or Nature of Title of Price of Date (Instr. (Instr. 3, Date Amount Secur- Owned at Indirect Indirect Derivative Deriv- (Month/ 8) 4 and 5) Exer- Expir- or Num- ity End of (I) Beneficial Security ative Day/ -------- ---------- cis- ation ber of (Instr. Month (Instr. Ownership (Instr. 3) Security Year) Code V (A) (D) able Date Title Shares 5) (Instr. 4) 5) (Instr. 5) - ---------- -------- -------- ---- --- ---- ---- ------- ----- ----- ------ ------ ---------- -------- ----------
Explanation of Responses: * The Reporting Person is the investment manager to The Aries Fund, A Cayman Island Trust, and disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein. The Reporting Person is the President and sole shareholder of Paramount Capital Asset Management, Inc., a Delaware Corporation, which is the investment manager to The Aries Fund, A Cayman Island Trust, and disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient. See Instruction 6 for procedure. /s/ Lindsay A. Rosenwald, M.D. 7/10/97 ---------------------------------------- -------------------- ** Signature of Reporting Person Date Lindsay A. Rosenwald, M.D. President, Paramount Capital Asset Management, Inc. Investment Manager, The Aries Fund, A Cayman Island Trust Page 3 of 3 -----END PRIVACY-ENHANCED MESSAGE-----